Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.3 USD | -0.00% | -1.86% | +12.21% |
14/05 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
06/05 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.21% | 652.84Cr | |
+40.62% | 5.4TCr | |
+45.83% | 4.2TCr | |
-1.94% | 4.19TCr | |
-7.20% | 2.84TCr | |
+11.62% | 2.64TCr | |
-21.43% | 1.9TCr | |
+5.21% | 1.3TCr | |
+29.12% | 1.23TCr | |
+25.34% | 1.22TCr |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation - Special Call